Edition:
United States

Search Results  for '300254.SZ'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Shanxi C&Y Pharmaceutical Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Company Snapshot - Shanxi Cy Pharmaceutical Co Ltd

A director at Shanxi Cy Pharmaceutical Co Ltd sold 10,000 shares at 22.110CNY and the significance rating of the trade was 52...

02 Nov 2016 Directors Deals Ltd. 1 $12.00

Thomson Reuters Stock Report - Shanxi C&Y Pharmaceutical Group Co Ltd (300254-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Shanxi C&Y Pharmaceutical Group Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 Oct 2016 Wright Reports 64 $75.00

Is There Long-Term Value in Shanxi C&Y Pharmaceutical Group Co Ltd?

10 Aug 2016 Sadif Analytics Prime 12 $25.00

Is Shanxi C&Y Pharmaceutical Group Co Ltd Still a Bargain?

11 May 2016 Sadif Analytics Prime 12 $25.00

Thomson Reuters Stock Report - Shanxi C&Y Pharmaceutical Group Co Ltd (300254-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Thomson Reuters Stock Report - Shanxi C&Y Pharmaceutical Group Co Ltd (300254-SZ)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Will Shanxi C&Y Pharmaceutical Group Co Ltd Bounce Back?

10 Feb 2016 Sadif Analytics Prime 12 $25.00

Shanxi C&Y Pharmaceutical Group Co Ltd: Downgraded to Average

31 Jul 2015 Sadif Analytics Prime 3 $10.00